Bharat Biotech’s Covaxin Gets Nod For Next Phase Of Trials On 2-18 Years Old
New Delhi: Bharat Biotech's Covid-19 vaccine Covaxin got approved by an expert panel on Tuesday for phase II and III human clinical trials on those between 2-18 years of age.
The Subject Expert Committee (SEC) on Covid-19 of the Central…
Read More...
Read More...